Ask us about IntraLASIK, implantable contacts, and ReSTOR / ReZOOM surgery!


Press Room
Click on a title below to view an article


Astronauts and LASIK


Scott L. Jaben, MD, Selected 2006/2007 Chair of the John K Robinson Loyalty Fund


Scott Jaben, MD, Celebrates 10 years as Medical Director at TLC Charlotte Laser Eye Center


The Dr. Scott and Hilary Jaben Speakers Fund for the Annual Freshman Pinning Ceremony at the Miller / University of Miami School of Medicine


Scott Jaben, MD, Is Offering The New Visian Implantable Contact Lens


Scott Jaben, MD, Is Offering the Newest In Cataract Lens Technology:
The AcrySof® ReSTOR® and the AMO ReZOOM Lens Implants


Scott L. Jaben, MD, Makes Charlotte Magazine's List of Best Doctors 2006


Bascom Palmer Eye Institute at the University of Miami RANKED BEST IN EYE CARE for 2006





















AMO's Advanced CustomVue(TM) LASIK with the IntraLase® Method Proves Ready for the Rigors of Space Travel

SANTA ANA, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE: EYE), a global leader in ophthalmic surgical devices and eye care products, today announced that the National Aeronautics and Space Agency (NASA) has approved the company's LASIK technologies for use on U.S. astronauts. The NASA decision was made following review of extensive military clinical data using AMO's Advanced CustomVue(TM) LASIK with the IntraLase® Method, which showed the combination of technologies provides superior safety and vision.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/intralase/29864/

Approved for use on consumers almost a decade ago, more than 11 million LASIK procedures have been performed to-date, making it the most-common elective surgical procedure in the U.S. But it wasn't until LASIK developed into an all-laser procedure that NASA approved it for use on pilots, mission and payload specialists who face extreme, physically demanding conditions in space. The all-laser LASIK technologies, which utilize wavefront guided and femtosecond lasers, have also been cleared for U.S. military personnel, including most recently Air Force pilots.

"NASA's approval is further evidence that today's LASIK exceeds all established standards of safety and effectiveness," said Steven Schallhorn, M.D., retired captain of the U.S. Navy, investigator in multiple studies involving use of LASIK and other refractive surgeries for treatment of nearsightedness, farsightedness and astigmatism, and Medical Director for Optical Express. "NASA followed the Naval Aviation clinical studies closely with a particular interest in both safety and quality of vision under extreme conditions. Wavefront guided and femtosecond lasers were proven to provide excellent safety with consistent visual results of 20/20 or better. LASIK was able to withstand even the most extreme rigors of warfare and flight. All surgical procedures have risks, but with this exceptional track record, the average consumer has nothing to fear from LASIK."

LASIK is a two-step procedure. The IntraLase® FS (femtosecond) laser replaces the hand-held microkeratome blade historically used in creating LASIK corneal flaps -- the first step of the procedure. The computer guided, ultra-fast laser virtually eliminates almost all of the most severe, sight threatening LASIK complications related to microkeratomes. The laser creates an optimal corneal surface below the flap, allowing for better visual outcomes from the second step of the procedure where wavefront guided technology maps, and then custom-corrects vision based upon the unique characteristics of an individual's eye. This sophisticated measurement provides 25 times more precision than measurements using standard methods for glasses and contact lenses.

LASIK'S FINAL FRONTIER
Though LASIK has been around for almost a decade, concerns about the harsh aviation environment prevented its use. To date, aeromedical professionals have been cautious of employing the procedure on military aviators who frequently encounter environmental extremes such as high altitude, dry air, wind blast and "G" forces. In space, these and other conditions add even higher levels of concern due to the extreme precision needed during flight and space walks.

Dr. Schallhorn, himself a retired naval aviator, spearheaded the majority of the Defense Department's research in laser vision correction. Some notable results of the many clinical trials conducted include:

An evaluation of Custom LASIK in 100 military personnel showed that 95 percent achieved 20/20 uncorrected vision or better; these patients, on average, were previously only able to read the first line (the big "E") of the vision assessment chart.(1)
In a study of different methods to create the LASIK flap, 370 naval personnel underwent bilateral wavefront-guided LASIK with either the femtosecond laser or microkeratome blade. One week after surgery more than 76 percent of femtosecond laser patients achieved an uncorrected visual acuity of at least 20/16 (better than 20/20) compared to 58 percent of microkeratome patients.(2)
In an evaluation of 785 aviators, 89% of Navy pilots rated their ability to land on an aircraft carrier as moderately to significantly better after laser vision correction. None said it was worse after surgery.(3)
A separate study determined that over 90 percent of marksmen had improvement in marksmanship skills after laser vision correction; a significant result given the visual precision of marksmen.(4)


"Today's news further validates AMO as the global leader in laser vision correction technologies," said Jim Mazzo, AMO chairman, president and CEO. "Our Advanced CustomVue(TM) LASIK with the IntraLase® Method is the only procedure in the U.S. to incorporate the technologies specifically approved for use by NASA."

In the U.S. laser vision correction market, the Advanced CustomVue(TM) LASIK procedure with the IntraLase® Method has become the new standard and is rapidly becoming the most widely performed laser vision correction procedure. In fact, the majority of premier ophthalmic teaching institutions, including Duke University Medical School, the Wilmer Eye Institute at Johns Hopkins, the Bascom Palmer Eye Institute at University of Miami, and Stanford University, totaling over 16 domestic and international teaching institutions use Advanced CustomVue(TM) LASIK with the IntraLase® Method to train the next generation of LASIK surgeons.

Advanced CustomVue(TM) LASIK with the IntraLase® Method
The Advanced CustomVue(TM) laser vision correction procedure stands in a class of its own with the broadest range of FDA-approved indications. When combined with the power and precision of the IntraLase® Method, the Advanced CustomVue(TM) procedure represents the most advanced LASIK procedure available to patients today. The IntraLase® FS laser, the first technology for a blade-free LASIK procedure, replaces the handheld microkeratome blade historically used in creating LASIK corneal flaps -- the first step of the procedure -- with a computer guided, ultra-fast femtosecond (fem-to-second) laser. The IntraLase® laser virtually eliminates the majority of the most severe sight-threatening LASIK complications related to use of the microkeratome.(5) Additionally, by creating an optimal corneal surface below the flap, the IntraLase® Method provides for better visual outcomes -- taking patients to 20/20 vision and beyond.(6) More than one million LASIK procedures using the IntraLase® Method have been performed. With the company's acquisition of IntraLase® Corp. in April of 2007, AMO is the only ophthalmic device manufacturer in the U.S. to market a femtosecond laser approved for use in creating LASIK corneal flaps and other corneal incisions.

About Advanced Medical Optics (AMO)
AMO develops advanced, life-improving vision technologies for people of all ages. Products in the cataract/implant line include intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and related products used in ocular surgery. AMO owns or has the rights to such product brands as ReZoom®, Tecnis®, Clariflex®, Sensar®, and Verisyse® IOLs, Sovereign®, Sovereign® Compact and WhiteStar Signature(TM) phacoemulsification systems with WhiteStar® technology, Healon® viscoelastics, and the Baerveldt® glaucoma shunt. Products in the laser vision correction line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems and treatment cards. AMO brands in the laser vision correction business include Star S4 IR®, WaveScan Wavefront®, Advanced CustomVue(TM), CustomVue®, IntraLase®, and IntraLasik®. Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE®, COMPLETE® Blink-N-Clean®, Consept®F, Consept® 1 Step, Oxysept® 1 Step, UltraCare®, Ultrazyme®, Total Care(TM) and blink(TM) branded products. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Website at http://www.amo-inc.com.

Forward-Looking Statements
This press release contains forward-looking statements about AMO, including statements by Dr. Schallhorn and Mr. Mazzo and statements relating to expected product performance, trends and outcomes. All forward-looking statements in this press release are based on estimates and assumptions and represent AMO's judgment only as of the date of this press release. Actual results may differ from current expectations based on a number of factors including but not limited to market developments, clinical experience, variations in surgeon experience, and unexpected regulatory, quality or supply issues. Therefore, the reader is cautioned not to rely on these forward-looking statements. AMO disclaims any intent or obligation to update these forward-looking statements. Additional information concerning these and other risk factors may be found in previous press releases issued by AMO and AMO's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in AMO's 2006 Form 10-K filed in March 2007 and second quarter Form 10-Q. Copies of press releases and additional information about AMO are available at http://www.amo-inc.com.
(1) Source: Captain (Retired) Steven C. Schallhorn, "US Navy study: Custom
PRK versus custom LASIK". Presented at the European Society of
Cataract and Refractive Surgeons annual meeting; September 8, 2006;
London, UK.
(2) Source: Tanzer DJ, Schallhorn SC. Comparison of visual outcomes with femtosecond and mechanical microkeratomes for wavefront-guided LASIK. Presented at the American Academy of Ophthalmology annual meeting; November 13, 2006; Las Vegas, NV.
(3) Source: Schallhorn SC, Tanzer DJ, 'Refractive Surgery in Naval Aviation', Presented at the Aerospace Medical Association annual meeting, May 15, 2006, Orlando, FL.
(4) Source: Captain (Retired) Steven C. Schallhorn, "Refractive Surgery in the Navy", Presented at the Aerospace Medical Association annual meeting; May 17, 1999; Detroit, Michigan.
(5) Source: Binder PS: "One thousand consecutive IntraLase laser in-sit keratomileusis flaps" Journal of Cataract and Refractive Surgery. V32. June 2005.
(6) Source: Durrie DS, Kezirian, GM: "Femtosecond Laser versus Mechanical Keratome Flaps in Wavefront-guided Laser in situ Keratomileusis:Prospective Contralateral Eye Study" Journal of Cataract and Refractive Surgery, V31, Jan. 2005.

SOURCE Advanced Medical Optics, Inc.

Back to top




Scott L. Jaben, MD, Selected 2006/2007
Chair of the John K Robinson Loyalty Fund

The Miller School of Medicine at the University of Miami, Florida, supports the legacy of Dr. John K Robinson, past Dean of the School of Medicine, through the John K Robinson Loyalty Fund.

This fund supports medical students at the University of Miami. 75 to 80% of the funds raised support scholarship aid to students who must qualify for consideration and maintain academic excellence and 5 to 10% goes to the newly created student grant program for students qualifying for funding to present personal and original research projects or participate in medical care initiatives.

Today it takes approximately $50,000 to make it through each and every year of medical school. Most students graduate with some form of loan obligation and the JKR Loyalty Fund works to lighten the financial burden on Miller Medical School students choosing medicine as their profession.

During Dr. Jabens first year as chair of this esteemed Fund, he worked with alumnus, foundations, and business organizations to increase giving more than 19% over last year. His goal for fiscal year 2007 is to assist more medical school students and raise even more money through alumnus education, activities and personal contact.

Scott L. Jaben, MD, is a proud graduate of the Miller School of Medicine at the University of Miami, Florida, class of 1977. His daughter is a second year student at the medical school. His legacy also lives on at the University through family, fellowship and service.


Back to top


Scott Jaben, MD, Celebrates 10 years as Medical Director
at TLC Charlotte Laser Eye Center

Scott L. Jaben, MD, has been practicing ophthalmology for more than 24 years in Charlotte. Currently, he is in group practice at Charlotte Eye Ear Nose and Throat Associates and serves as one of two medical directors at TLC Charlotte Laser Eye Center. Completing his first LASIK procedure in 1996, Dr. Jaben celebrates 10 years with TLC.

As a medical director, Dr. Jaben provides Laser Vision Correction procedures on his own patients as well as patients referred to TLC by local optometrists and ophthalmologists that dont offer LASIK. They trust their patients to Dr. Jaben and TLC.

Dr. Jaben has watched LASIK technology evolve over the past ten years into a customized surgery for patients. Technology has come a long way in 10 years and I think this procedure will just keep getting better, says Jaben. But technology is only one part of the equation, the surgeons experience and the quality of the laser facility make up the other two-thirds and I am proud to be affiliated with TLC-Charlotte.

Dr. Jaben experienced LASIK for himself in 1999. His LASIK surgeon was his mentor and co-founder of the TLC Company, Jeffrey Machat, MD. I decided that I would be a much better LASIK surgeon, if I also experienced LASIK as a patient. Today, I am still 20/20 and I feel like I can really relate to my patients as they take their LASIK journey.

Knowing that more than fifteen million LASIK procedures have been performed worldwide is reassuring..so is knowing that over 800,000 surgeries have been performed at TLC Laser Eye Centers. But we believe that when it comes to results, the most important number of all is one.


Back to top



The Dr. Scott and Hilary Jaben Speakers Fund
for the Annual Freshman Pinning Ceremony at the
Miller / University of Miami School of Medicine

Dr. Scott Jaben fondly remembers his days as a medical student at the University of Miami School of Medicine. One of the medical schools highlights is the annual Freshman Pinning Ceremony. This ceremony welcomes first-year medical students to the University of Miami School of Medicine and to the profession of medicine.

At this esteemed event, fourth-year medical students and alumni of the School of Medicine pin freshman students. Each year, a distinguished speaker addresses the students, families and guests.

Dr. Jaben and his wife, Hilary, established an endowment at the school with proceeds funding the speaker at this annual event. Hilary and I were most interested in enriching the lives of the medical students at UM, says Jaben. We both agreed that a speaker series for the medical students would be a terrific way to make a lasting contribution.

After receiving his medical degree, Dr. Jaben served as chief resident and went on to complete a vitreoretinal fellowship at Bascom Palmer Eye Institute, ranked one of the best eye hospitals in the nation. He currently works in private practice at Charlotte Eye Ear Nose and Throat Associates.


Back to top



Scott Jaben, MD, Is Offering The New Visian Implantable Contact Lens

Scott Jaben, MD, is offering the new Visian Implantable Contact Lens (ICL) for people wishing to eliminate their dependency on glasses and contacts. This new procedure is an alternative to LASIK surgery for those people who are non-LASIK candidates due to extreme nearsightedness or thin corneas, or those people who wish to have a non-permanent procedure.

The best candidates for this procedure are those people aged 21-45, with moderate to severe myopia (-3 to -20 diopters), and mild or no astigmatism. Please note that patients in their 50-60s can have the implant, but they will still need reading glasses as it does not correct presbyopia. It only corrects distance vision.

The advantage the procedure allows correction of your distance vision without removing corneal tissue, making the implantable contact lens a non-permanent, changeable surgery.

Dr. Jaben is a skilled ophthalmologist with more than 24 years of surgical experience. He has completed more than 21,000 cataract surgeries and 7000 LASIK procedures. The Implantable Contact Lens surgery is very similar to cataract surgery. The procedure is performed at an outpatient surgery center and usually only one eye is done per surgery day. Numbing drops or a local injection are used for comfort. The lens is implanted behind the iris, or colored part of the eye. Your surgeon injects the folded lens into the anterior chamber through a tiny incision at the clear edge of the cornea where it unfolds and moves into position. It is less involved than cataract surgery because your natural crystalline lens is not removed. Comfort drops or oral medications may be prescribed and the surgeon schedules an appointment to see you later the same day for a pressure check and again the next day. You will continue to see the surgeon on a regular basis for the first 6 months. After that, your surgeon will likely recommend a yearly eye exam to check your vision and the health of your eye.

The Visian ICL is made of a long-lasting Collamer material and is designed to stay in the eye without maintenance. If it becomes necessary to remove the lens, your surgeon can easily do this for you.

The ICL was approved by the US Food and Drug Administration in December 2005. In a clinical study of 294 patients implanted with the Visian ICL, 95 percent had 20/40 or better vision (necessary for a drivers license), and 59 percent had 20/20 or better vision after three years. Over 60,000 ICLs have been implanted worldwide over the past 5 years with similar success.

Dr. Jaben offers a complimentary two-part consultation to determine candidacy. The first appointment is at our SouthPark office and consists of a complete clinical work-up, the second appointment is a 30-minute consultation with Dr. Jaben to discuss your results and determine your interest.

If you would like to schedule your complimentary consultation, please call Karon Petty at 704/295-3777. She will be happy to answer your questions and assist with scheduling.

In addition to the Implantable Contact Lens, Dr. Jaben also offers other procedures to eliminate glasses and contacts. They are conventional and cusom LASIK, the new ReSTOR lens, and NearVision CK (to eliminate reading glasses). Please visit this website to learn more about these procedures.


Back to top


Scott Jaben, MD, Is Offering the Newest In Cataract Lens Technology:
The AcrySof® ReSTOR® and the AMO ReZOOM Lens Implants

These intraocular lens implants (IOLs) are designed for people with cataracts and presbyopia (the need for reading glasses).

As we age into our 40s, we begin to notice that our near vision is failing. These people find themselves needing glasses, maybe for the first time in their lives. Presbyopia is a condition where near vision is compromised and reading glasses or bifocals are necessary. Millions of Americans become presbyopic each year.

People at any age and especially those entering into their 60s may start to notice their vision is not as crisp as it once was indicating a cataract may be forming or growing. Cataracts affect millions of Americans. It is the clouding of the eye's natural lens, which is positioned behind the iris (the colored part of your eye). It works like the lens of a camera focusing light images on the retina which sends the image to your brain. People with a cataract begin to notice that images are blurred, bright colors seem dull and seeing at night is difficult. The best way to treat a cataract is to remove the clouded lens and replace it.

Until recently, most patients had their vision improved with a monofocal IOL. It improved the quality of their distance vision, but most patients still needed to wear reading glasses. With the introduction of the new FDA-approved AcrySo®f ReSTOR® IOL and the AMO ReZOOM IOL, many people will enjoy freedom from glasses and contacts. This new lens provides a full range of vision, decreasing or eliminating dependency on reading glasses or bifocals. Let's discuss these lenses further.

Whether for cataracts or presbyopia, all surgery patients will notice their vision is significantly better when the clouded lens is removed and an artificial lens called an intraocular lens implant (IOL) is surgically implanted. The traditional or most commonly used IOL is the monofocal type or single vision implant. It is usually designed to correct just distance vision. It improves the quality of the distance vision often without the use of any glasses after surgery, however, up to 90 percent or more of patients need glasses for reading and approximately 50 percent will still need glasses for distance. Most patients resort to bifocal glasses, similar to the ones they were using prior to surgery.

Not all patients who receive the AcrySof® ReSTOR® IOL and the AMO ReZOOM IOL will be spectacle free. Proper patient selection and screening must be employed to be successful. Age, functional and occupational requirements, degree of general alertness, and ocular health must all be taken into account. Patient satisfaction with this technology will be based on setting realistic expectations.

The AcrySof® ReSTOR® and the AMO ReZOOM multifocal lenses offer most patients what monofocal lenses cannot the ability to have both near and distance vision without glasses. If the idea of wearing corrective eyewear is frustrating and unappealing, this may be the solution for you. Ask your eye doctor if you are a candidate for the AcrySof® ReSTOR® and the AMO ReZOOM multifocal lens implants.



Back to top



Scott L. Jaben, MD, Makes Charlotte Magazines List of Best Doctors 2006
For the past several years, Scott L. Jaben, MD, board certified/fellowshipped ophthalmologist at Charlotte Eye Ear Nose and Throat Associates and TLC Charlotte Laser Eye Center, has been selected to Charlotte Magazines Best Doctors list and 2006 is no exception.
Best Doctors, Inc, annually surveys the top physicians in the greater Charlotte area to find out which doctors they would choose for their family members. The entire list can be found in the July 2006 issue of Charlotte Magazine.
Congratulations Dr. Jaben on being selected a Best Doctor in Charlotte.
For more information on Dr. Jaben, see the About Dr. Jaben menu bar on the home page of this website.



Back to top


Bascom Palmer Eye Institute at the University of Miami RANKED BEST IN EYE CARE for 2006
 
The University of Miami's Bascom Palmer Eye Institute has been ranked the nation's best hospital for eye care for the third year in a row by U.S. News and World Report.
The institute has been ranked No. 1 five times in the past 12 years.
Dr. Jaben completed his medical training at the MILLER School of Medicine / University of Miami, and his ophthalmology residency and vitreoretinal diseases fellowship at the Bascom Palmer Eye Institute, University of Miami.
The magazine's annual Best Hospitals guide is available July 2006.
For more information on this ranking, visit www.USnews.com and view the July 9, 2006 issue of US News and World Report.


Back to top

copyright Scott L. Jaben, M.D.